These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 7903976

  • 1. A randomized pilot study of alternating or simultaneous zidovudine and didanosine therapy in patients with symptomatic human immunodeficiency virus infection.
    Yarchoan R, Lietzau JA, Nguyen BY, Brawley OW, Pluda JM, Saville MW, Wyvill KM, Steinberg SM, Agbaria R, Mitsuya H.
    J Infect Dis; 1994 Jan; 169(1):9-17. PubMed ID: 7903976
    [Abstract] [Full Text] [Related]

  • 2. Randomized study of didanosine monotherapy and combination therapy with zidovudine in hemophilic and nonhemophilic subjects with asymptomatic human immunodeficiency virus-1 infection. AIDS Clinical Trial Groups.
    Ragni MV, Amato DA, LoFaro ML, DeGruttola V, Van Der Horst C, Eyster ME, Kessler CM, Gjerset GF, Ho M, Parenti DM.
    Blood; 1995 May 01; 85(9):2337-46. PubMed ID: 7727768
    [Abstract] [Full Text] [Related]

  • 3. Zidovudine and didanosine combination therapy in children with human immunodeficiency virus infection.
    Husson RN, Mueller BU, Farley M, Woods L, Kovacs A, Goldsmith JC, Ono J, Lewis LL, Balis FM, Brouwers P.
    Pediatrics; 1994 Feb 01; 93(2):316-22. PubMed ID: 7907174
    [Abstract] [Full Text] [Related]

  • 4. A pilot study of sequential therapy with zidovudine plus acyclovir, dideoxyinosine, and dideoxycytidine in patients with severe human immunodeficiency virus infection.
    Nguyen BY, Shay LE, Wyvill KM, Pluda JM, Brawley O, Cohen RB, Whitcup SM, Venzon DJ, Broder S, Yarchoan R.
    J Infect Dis; 1993 Oct 01; 168(4):810-7. PubMed ID: 8397267
    [Abstract] [Full Text] [Related]

  • 5. Human immunodeficiency virus type 1 (HIV-1) viremia changes and development of drug-related mutations in patients with symptomatic HIV-1 infection receiving alternating or simultaneous zidovudine and didanosine therapy.
    Kojima E, Shirasaka T, Anderson BD, Chokekijchai S, Steinberg SM, Broder S, Yarchoan R, Mitsuya H.
    J Infect Dis; 1995 May 01; 171(5):1152-8. PubMed ID: 7751690
    [Abstract] [Full Text] [Related]

  • 6. Combination therapy with zidovudine and didanosine compared with zidovudine alone in HIV-1 infection.
    Collier AC, Coombs RW, Fischl MA, Skolnik PR, Northfelt D, Boutin P, Hooper CJ, Kaplan LD, Volberding PA, Davis LG, Henrard DR, Weller S, Corey L.
    Ann Intern Med; 1993 Oct 15; 119(8):786-93. PubMed ID: 8379600
    [Abstract] [Full Text] [Related]

  • 7. Nevirapine, zidovudine, and didanosine compared with zidovudine and didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group Protocol 241 Investigators.
    D'Aquila RT, Hughes MD, Johnson VA, Fischl MA, Sommadossi JP, Liou SH, Timpone J, Myers M, Basgoz N, Niu M, Hirsch MS.
    Ann Intern Med; 1996 Jun 15; 124(12):1019-30. PubMed ID: 8633815
    [Abstract] [Full Text] [Related]

  • 8. A randomized trial (ISS 902) of didanosine versus zidovudine in previously untreated patients with mildly symptomatic human immunodeficiency virus infection.
    Floridia M, Vella S, Seeber AC, Tomino C, Fragola V, Weimer LE, Ricciardulli D, Milazzo F, Gritti FM, Mazzotta F, Ranieri S, Chiodo F, Moroni M, Cargnel A, Bassetti D, Giannini V, Cremoni L, Concia E, Sinicco A, Carosi G, Alberici F, Dianzani F.
    J Infect Dis; 1997 Feb 15; 175(2):255-64. PubMed ID: 9203645
    [Abstract] [Full Text] [Related]

  • 9. Combination therapy with zidovudine and dideoxycytidine in patients with advanced human immunodeficiency virus infection. A phase I/II study.
    Meng TC, Fischl MA, Boota AM, Spector SA, Bennett D, Bassiakos Y, Lai SH, Wright B, Richman DD.
    Ann Intern Med; 1992 Jan 01; 116(1):13-20. PubMed ID: 1345755
    [Abstract] [Full Text] [Related]

  • 10. Results of the ALBI trial: a randomized comparison of stavudine/didanosine, zidovudine/lamivudine and alternating treatment in antiretroviral-naive patients.
    Molina JM, Chêuc G, Ferchal F, Journot V, Pellegrin I, Sombardier MN, Rancinan C, Cotte L, Madelaine I, Debord T, Decazes JM, ALBI (ANRS 070) Study Group.
    Antivir Ther; 1999 Jan 01; 4 Suppl 3():71-4. PubMed ID: 16021874
    [Abstract] [Full Text] [Related]

  • 11. Didanosine compared with continued zidovudine therapy for HIV-infected patients with 200 to 500 CD4 cells/mm3. A double-blind, randomized, controlled trial. Canadian HIV Trials Network Protocol 002 Study Group.
    Montaner JS, Schechter MT, Rachlis A, Gill J, Beaulieu R, Tsoukas C, Raboud J, Cameron B, Salomon H, Dunkle L, Smaldone L, Wainberg MA.
    Ann Intern Med; 1995 Oct 15; 123(8):561-71. PubMed ID: 7677296
    [Abstract] [Full Text] [Related]

  • 12. Use of didanosine in zidovudine-intolerant patients infected with human immunodeficiency virus.
    Nelson MR, Moyle GJ, Gazzard BG.
    Clin Infect Dis; 1993 Feb 15; 16 Suppl 1():S59-62. PubMed ID: 8093848
    [Abstract] [Full Text] [Related]

  • 13. Switching from zidovudine to didanosine in patients with symptomatic HIV infection and disease progression. ddI Iberian Study Group.
    Gatell JM, González-Lahoz J, Clotet B, Antunes F, Kasparova L, Gil-Aguado A, Saballs P, Santamaria JM, Podzamczer D, Miro JM, Jou A, Verdejo J, Doroana M, Thomis J.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Jul 15; 12(3):249-58. PubMed ID: 8673528
    [Abstract] [Full Text] [Related]

  • 14. Alternating treatment with didanosine and zidovudine versus either drug alone for the treatment of advanced HIV infection. The Alter Study. Nordic HIV Therapy Group.
    Gerstoft J, Melander H, Bruun JN, Pedersen C, Głtzsche PC, Berglund O, Mathiesen L, Skinhłj P, Norrby SR.
    Scand J Infect Dis; 1997 Jul 15; 29(2):121-8. PubMed ID: 9181646
    [Abstract] [Full Text] [Related]

  • 15. Dideoxyinosine in children with symptomatic human immunodeficiency virus infection.
    Butler KM, Husson RN, Balis FM, Brouwers P, Eddy J, el-Amin D, Gress J, Hawkins M, Jarosinski P, Moss H.
    N Engl J Med; 1991 Jan 17; 324(3):137-44. PubMed ID: 1670591
    [Abstract] [Full Text] [Related]

  • 16. A controlled trial comparing continued zidovudine with didanosine in human immunodeficiency virus infection. The NIAID AIDS Clinical Trials Group.
    Kahn JO, Lagakos SW, Richman DD, Cross A, Pettinelli C, Liou SH, Brown M, Volberding PA, Crumpacker CS, Beall G.
    N Engl J Med; 1992 Aug 27; 327(9):581-7. PubMed ID: 1353607
    [Abstract] [Full Text] [Related]

  • 17. Didanosine therapy in patients intolerant of or failing zidovudine therapy.
    Rathbun RC, Martin ES.
    Ann Pharmacother; 1992 Nov 27; 26(11):1347-51. PubMed ID: 1362093
    [Abstract] [Full Text] [Related]

  • 18. A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study Team.
    Hammer SM, Katzenstein DA, Hughes MD, Gundacker H, Schooley RT, Haubrich RH, Henry WK, Lederman MM, Phair JP, Niu M, Hirsch MS, Merigan TC.
    N Engl J Med; 1996 Oct 10; 335(15):1081-90. PubMed ID: 8813038
    [Abstract] [Full Text] [Related]

  • 19. The use and toxicity of didanosine (ddI) in HIV antibody-positive individuals intolerant to zidovudine (AZT).
    Moyle GJ, Nelson MR, Hawkins D, Gazzard BG.
    Q J Med; 1993 Mar 10; 86(3):155-63. PubMed ID: 8387218
    [Abstract] [Full Text] [Related]

  • 20. Zidovudine compared with didanosine in patients with advanced HIV type 1 infection and little or no previous experience with zidovudine. AIDS Clinical Trials Group.
    Dolin R, Amato DA, Fischl MA, Pettinelli C, Beltangady M, Liou SH, Brown MJ, Cross AP, Hirsch MS, Hardy WD.
    Arch Intern Med; 1995 May 08; 155(9):961-74. PubMed ID: 7726705
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.